Explore
Reuters
Lilly's obesity pill Foundayo gets 1,390 prescriptions in debut week
April 17 (Reuters) - Eli Lilly's newly launched obesity pill was prescribed 1,390 times in the U.S. as of the week ended April 10, according to an analyst who cited IQVIA data. Novo Nordisk's oral Wegovy had hit 3,071 U.S. prescriptions in the first four days after its launch on January 5.
Read More
Reuters
Aerospace parts maker Arxis raises $1.13 billion in US IPO
April 15 (Reuters) - Aerospace parts maker Arxis said on Wednesday it raised $1.13 billion in its U.S. initial public offering after pricing shares at $28 each.
Read More
Reuters
Nasdaq sets record highs as investors return to tech stocks
April 15 (Reuters) - The Nasdaq hit an intraday all-time high and closing record on Wednesday, its first since October, as investors returned to technology stocks, signaling a rebound in risk appetite after weeks of concerns over war-related economic disruption and fears about the labor-force impact
Read More
Reuters
Arxis surges in Nasdaq debut, signals strong demand for aerospace IPOs
By Manya Saini April 16 (Reuters) - Aerospace and defense parts maker Arxis' shares surged nearly 36% in their Nasdaq debut on Thursday, signaling growing appetite for defense and industrial listings as geopolitical tensions escalate.
Read More
Reuters
Drone maker AEVEX raises $320 million in US IPO
April 16 (Reuters) - Drone maker AEVEX said on Thursday that it had raised $320 million in its U.S. initial public offering after pricing shares at $20 each. The Solana Beach, California-based company sold 16 million shares within its indicated price range of $18 to $21 apiece.
Read More
Reuters
Nuclear reactor developer X‑Energy targets $7.5 billion valuation in US IPO
April 15 (Reuters) - Amazon-backed X-Energy said on Wednesday it was targeting a valuation of up to $7.51 billion in its initial public offering in the United States.
Read More
Reuters
Madison Air raises $2.2 billion in US IPO
April 15 (Reuters) - Indoor air systems provider Madison Air Solutions said on Wednesday it had raised $2.23 billion in its U.S. initial public offering. The Chicago, Illinois-based company sold 82.7 million shares in the IPO at $27 each, compared with the marketed range of $25 to $27.
Read More
Reuters
Instant View: S&P 500, Nasdaq notch fresh records, casting aside war fears
NEW YORK, April 15 (Reuters) - U.S. stock indexes returned to new highs on Wednesday, putting fears of economic disruption driven by the war with Iran in the rearview mirror.
Read More
Reuters
Myseum takes flight after Allbirds in fresh AI rebrand wave
By Shashwat Chauhan April 16 (Reuters) - A day after footwear maker Allbirds rose 582% on its plan to "pivot its business to AI compute infrastructure," social media firm Myseum was up 181% early on Thursday in the latest sign of an investor mania for artificial intelligence stocks.
Read More
Reuters
Drone maker AEVEX valued at $2.6 billion as shares rise in NYSE debut
April 17 (Reuters) - Drone maker AEVEX's shares jumped 15% in their debut on the New York Stock Exchange on Friday, signaling growing investor appetite for defense-linked businesses as governments ramp up military spending amid persisting geopolitical tensions.
Read More
Reuters
Wall St futures edge higher on Mideast diplomacy hopes, strong earnings
April 16 (Reuters) - U.S. stock index futures inched higher on Thursday as investors grew more confident that the worst of the Middle East conflict had passed, while a wave of solid earnings allayed concerns about the economy.
Read More
Trendline
Biotech Companies Alamar, Hemab, Kailera, and Seaport Advance IPO Plans on Nasdaq
Biotech Companies Alamar, Hemab, Kailera, and Seaport Advance IPO Plans on Nasdaq
Read More
